Image

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

Join a study for kidney cancer with combination immunotherapy.

Recruiting
18 years and older
All
Phase 2

The study is for patients with advanced kidney cancer, known as renal cell carcinoma (RCC), that has spread to other parts of the body. It compares two combinations of drugs: botensilimab and balstilimab versus ipilimumab and nivolumab. These drugs are part of a treatment called immunotherapy, which helps your immune system fight cancer. The study aims to include 120 patients and will last for up to 96 weeks. During this time, doctors will watch for side effects and see how well the cancer responds to treatment.

  • Participants will need to visit the clinic regularly for check-ups and treatment.
  • The study lasts up to 96 weeks, depending on your response to treatment.
  • Risks include possible side effects from the drugs, which will be closely monitored.

To join, you must be at least 18, have a type of RCC, and meet specific health criteria. You cannot join if you have had certain previous treatments or health issues. If you are considering joining, please discuss it with your doctor to understand the benefits and risks.

Study details
    Advanced Renal Cell Carcinoma

NCT05928806

Michael B. Atkins, MD

20 April 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.